Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 3, p. 136, doi. 10.12793/tcp.2020.28.e16
- By:
- Publication type:
- Article
Works matching AU Sukyong Yoon
Results: 6
1
2
Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 1, p. 55, doi. 10.12793/tcp.2020.28.e5
- By:
- Publication type:
- Article
3
Model-informed precision dosing in vancomycin treatment.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1252757
- By:
- Publication type:
- Article
4
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2023, v. 19, n. 7, p. 479, doi. 10.1080/17425255.2023.2249397
- By:
- Publication type:
- Article
5
Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 150, doi. 10.12793/tcp.2021.29.e15
- By:
- Publication type:
- Article
6
Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 3, p. 334, doi. 10.3390/pharmaceutics16030334
- By:
- Publication type:
- Article